EXCLUSIVE: Greater than 20 Republican attorneys common are demanding that the Trump administration reinstate security protocols for the abortion drug mifepristone, saying it poses “critical dangers to ladies.”
In a letter obtained by Fox Information Digital, 22 attorneys common known as on Well being and Human Companies Secretary Robert F. Kennedy Jr. and Meals and Medication Administration head Martin Makary to carry again safeguards for the tablets that had been scrapped by the Obama and Biden administrations.
“Latest complete research of the real-world results of the chemical abortion drug mifepristone report that critical antagonistic occasions happen 22 occasions extra typically than said on the drug’s label, whereas the drug is lower than half as efficient as claimed. These info instantly contradict the drug’s major advertising and marketing message of ‘secure’ and ‘efficient,'” the letter reads, citing research revealed earlier this 12 months by the Ethics and Public Coverage Heart (EPPA), a Washington, D.C.-based advocacy group.
The EPPA report claims the tablet presents hurt to ladies, inflicting 1 in 10 sufferers to expertise a “critical antagonistic occasion,” together with hemorrhage, emergency room visits and ectopic being pregnant.
FDA CHIEF HAS ‘NO PLANS’ FOR ABORTION PILL POLICY CHANGES BUT CONTINUES SAFETY REVIEW
The letter, led by Kansas Legal professional Basic Kris Kobach, comes after Kennedy Jr. requested Makary to overview the most recent information on mifepristone and its security.
“Based mostly on that overview, the FDA ought to think about reinstating security protocols that it recognized as essential as lately as 2011 in its issuance of a Danger Analysis and Mitigation Technique (REMS) for mifepristone, however which had been eliminated by the Obama and Biden administrations,” the letter reads, including that the drug needs to be taken off the market if safeguards can’t be put in place.
“Alternatively, in mild of the intense dangers to ladies who’re presently being prescribed this drug with out essential safeguards, and within the occasion the FDA is unable to reinstate the 2011 security protocols for mifepristone, the FDA ought to think about withdrawing mifepristone from the market till it completes its overview and might resolve on a plan of action primarily based on goal security and efficacy standards,” the attorneys common wrote.
Sen. Josh Hawley, R-Mo., additionally despatched a letter to Kennedy Jr. final month urging him to take instant motion to reinstate security guardrails on mifepristone following the secretary’s dedication to conducting a security overview of the drug.
Makary had beforehand stated that he had no plans to switch insurance policies surrounding mifepristone however that the FDA would act if the info prompt there was a security challenge.
Mifepristone, which is taken with one other drug known as misoprostol to finish an early being pregnant, was first permitted by the FDA in 2000 after “an intensive and complete overview” discovered it was secure and efficient, based on the company’s web site, which famous that periodic critiques since its approval haven’t recognized new security issues.
Final 12 months, the Supreme Court docket rejected a problem concentrating on the drug’s availability. The plaintiffs had sought to limit entry to mifepristone throughout the nation, together with in Democrat-led states the place abortion stays authorized. The courtroom didn’t rule on whether or not the FDA acted lawfully when it moved through the Obama and Biden administrations to ease the principles for mifepristone’s use that had been established through the Clinton administration.
Treatment abortions made up greater than half of all abortions within the U.S. well being care system in 2023, based on a examine by the Guttmacher Institute.
MEDICAL GROUPS URGE FDA, KENNEDY TO REEXAMINE BROAD APPROVAL OF ABORTION DRUGS
CLICK HERE TO GET THE FOX NEWS APP
“Presently, a girl can acquire a mifepristone abortion by collaborating in just one telehealth go to with any permitted healthcare supplier (not essentially a doctor), ordering the medication by way of a mail-order pharmacy, and self-administering them,” the attorneys common wrote. “And the prescriber is barely required to report an antagonistic occasion if she or he turns into conscious that the affected person has died.”
“The FDA’s removing of those essential security protocols in 2016 (and in 2023) that solely 5 years earlier than the FDA thought of essential begs the query of whether or not the removing was motivated by concerns apart from the protection of sufferers … The present FDA’s dedication to the well being and wellbeing of all People is encouraging, as is the much-needed overview of mifepristone that Secretary Kennedy has promised,” the letter concludes.
